Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
No Data
Anatara Weighs Next Steps for Obesity Candidate as Cash Tightens and Portfolio Review Continues
Anatara Lifesciences Seeks ASX Quotation for 2.36m New Shares
Anatara Lifesciences Converts 2.36 Million Performance Rights Into Ordinary Shares
Anatara Lifesciences Narrows Half-Year Loss as Revenue Slides
Anatara Lifesciences Ltd: Appendix 4D & Half Year Report 31 December 2025
Anatara Flags Promising Anti-Obesity Data as Capital Raise Bolsters Pipeline Plans